APIE Therapeutics Appoints Ashwin Datt Chief Executive Officer

2 years ago

Former CEO and Founder, Esther Alegria Remains on Executive Team Focused on Driving Research & Development Through External CollaborationsResearch Triangle…

Mendus publishes prospectus regarding previously announced rights issue and directed issue

2 years ago

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES…

electroCore Provides Select Second Quarter 2023 Financial Guidance

2 years ago

Record revenue of approximately $3,550,000 for the three months ended June 30, 2023; 65% increase over second quarter of 2022ROCKAWAY,…

TRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma

2 years ago

Collection of Award Extends Cash Runway into early 2024 and Past Expected Full Accrual of the ENVASARC Pivotal TrialSAN DIEGO,…

STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris

2 years ago

HORSHAM, Pa., July 11, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to…

Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD

2 years ago

Results Indicative that CTx-1301 Provides Entire Active-Day Efficacy with Optimal Onset and DurationKANSAS CITY, Kan., July 11, 2023 (GLOBE NEWSWIRE)…

Daré Bioscience Announces Additional Positive Data from Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women

2 years ago

Sildenafil Cream Demonstrated Statistically Significant Improvement in Sexual Desire, an Exploratory Endpoint; Improvements in Arousal Lubrication, Orgasm and Sexual Desire…

Recce Pharmaceuticals Announces First Cohort Dosed in RECCE® 327 Rapid Infusion Phase I/II Urinary Tract Infection (UTI) Clinical Trial

2 years ago

Highlights: First cohort in Phase I/II urinary tract infection (UTI) rapid infusion intravenous (IV) study successfully dosed 2,500mg of RECCE®…

Longeveron Appoints Dr. Nataliya Agafonova as Chief Medical Officer

2 years ago

Experienced Pharma Industry Clinical Operations Leader to Spearhead Development of Cellular Therapy ProgramsMIAMI, July 11, 2023 (GLOBE NEWSWIRE) -- Longeveron…